1) Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 : 784-789, 2001
2) Takata S, Ito M, Yoshihara M, et al. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori. J Gastroenterol Hepatol 22 : 571-576, 2007
3) Mihara M, Haruma K, Kamada T, et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection : evaluation in a country with high prevalence of atrophic gastritis. Helicobacter 4 : 40-48, 1999
4) Yagi K, Nakamura A, Sekine A. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol Hepatol 17 : 39-45, 2002
5) Egi Y, Ito M, Tanaka S, et al. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia. J Clin Oncol(in press).
6) Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori : results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 21 : 1121-1126, 2005
7) Ito M, Tanaka S, Takata S, et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther 21 : 559-566, 2005
8) Ito M, Tanaka S, Kamada T, et al. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 12 : 10-16, 2006
9) You WC, Broun LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 98 : 974-983, 2006